Argentina requires manufacturers to revise registrations
This article was originally published in SRA
Argentina’s National Medicines, Food and Medical Technology Administration, ANMAT, has issued the deadlines by which device companies must obtain a full registration for products that were provisionally registered while the country transitioned to harmonised requirements agreed by the Mercosur countries (Argentina, Brazil, Paraguay and Uruguay)1.
You may also be interested in...
ANMAT, Argentina's drug and healthcare products regulatory agency, has issued a regulation establishing the minimum requirements that companies need to follow in order to switch their product from prescription-only to over-the-counter status1.
Argentina's National Medicines, Food and Medical Technology Administration, ANMAT, has developed a new strategy to generate timely national and international information about the products and processes within its remit, so that the regulator can identify problems affecting public health and propose appropriate actions1.
Argentina's Ministry of Health has recently stepped up its efforts to combat tropical diseases and cancer.